Evidence map›Paper›PMID 29088097›Full record

ArticleInternational journal of molecular sciences2017

The Relevance of the UPS in Fatty Liver Graft Preservation: A New Approach for IGL-1 and HTK Solutions.

Arnau Panisello-Roselló, Eva Verde, Mohamed Amine Zaouali, Marta Flores, Norma Alva, Alexandre Lopez, Emma Folch-Puy, Teresa Carbonell, Georgina Hotter, René Adam and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Ubiquitin System.International journal of molecular sciences · 2018
    Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Arnau Panisello-RosellóExperimental Hepatic Ischemia-Reperfusion Unit, Institut d'Investigacions Biomèdiques de Barcelona (IIBB), Spanish National Research Council (CSIC), 08036 Barcelona, Catalonia, Spain. arnau.panisello.rosello@gmail.com.
Eva VerdeFaculty of Biology, Universitat de Barcelona, 08028 Barcelona, Catalonia, Spain. e.vaaverde@gmail.com.
Mohamed Amine ZaoualiExperimental Hepatic Ischemia-Reperfusion Unit, Institut d'Investigacions Biomèdiques de Barcelona (IIBB), Spanish National Research Council (CSIC), 08036 Barcelona, Catalonia, Spain. daminzaouali12@yahoo.fr.
Marta FloresFaculty of Biology, Universitat de Barcelona, 08028 Barcelona, Catalonia, Spain. mfloreso10@alumnes.ub.edu.
Norma AlvaFaculty of Biology, Universitat de Barcelona, 08028 Barcelona, Catalonia, Spain. nvalva@ub.edu.
Alexandre LopezCentre Hépato-Biliaire, AP-PH, Hôpital Paul Brousse, 94800 Paris, France. alexandregl.lopez@gmail.com.
Emma Folch-PuyExperimental Hepatic Ischemia-Reperfusion Unit, Institut d'Investigacions Biomèdiques de Barcelona (IIBB), Spanish National Research Council (CSIC), 08036 Barcelona, Catalonia, Spain. emma.folch@iibb.csic.es.
Teresa CarbonellFaculty of Biology, Universitat de Barcelona, 08028 Barcelona, Catalonia, Spain. tcarbonell@ub.edu.
Georgina HotterExperimental Hepatic Ischemia-Reperfusion Unit, Institut d'Investigacions Biomèdiques de Barcelona (IIBB), Spanish National Research Council (CSIC), 08036 Barcelona, Catalonia, Spain. ghcbam@iibb.csic.es.
René AdamCentre Hépato-Biliaire, AP-PH, Hôpital Paul Brousse, 94800 Paris, France. rene.adam@aphp.fr.
Joan Roselló-CatafauExperimental Hepatic Ischemia-Reperfusion Unit, Institut d'Investigacions Biomèdiques de Barcelona (IIBB), Spanish National Research Council (CSIC), 08036 Barcelona, Catalonia, Spain. jrcbam@iibb.csic.es.
Consejo Superior de Investigaciones Científicas · ESUniversitat de Barcelona · ESHôpital Paul-Brousse · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The 26S proteasome is the central proteolytic machinery of the ubiquitin proteasome system (UPS), which is involved in the degradation of ubiquitinated protein substrates. Recently, UPS inhibition has been shown to be a key factor in fatty liver graft preservation during organ cold storage using University of Wisconsin solution (UW) and Institute Georges Lopez (IGL-1) solutions. However, the merits of IGL-1 and histidine-tryptophan-ketoglutarate (HTK) solutions for fatty liver preservation have not been compared. Fatty liver grafts from obese Zücker rats were preserved for 24 h at 4 °C. Aspartate aminotransferase and alanine aminotransferase (AST/ALT), glutamate dehydrogenase (GLDH), ATP, adenosine monophosphate protein kinase (AMPK), e-NOS, proteasome activity and liver polyubiquitinated proteins were determined. IGL-1 solution prevented ATP breakdown during cold-storage preservation of steatotic livers to a greater extent than HTK solution. There were concomitant increases in AMPK activation, e-NOS (endothelial NOS (NO synthase)) expression and UPS inhibition. UPS activity is closely related to the composition of the solution used to preserve the organ. IGL-1 solution provided significantly better protection against ischemia-reperfusion for cold-stored fatty liver grafts than HTK solution. The effect is exerted through the activation of the protective AMPK signaling pathway, an increase in e-NOS expression and a dysregulation of the UPS.

Indexed as

Adenosine TriphosphateAlanine TransaminaseAMP-Activated Protein Kinase KinasesAnimalsAspartate AminotransferasesFatty LiverGlucoseGlutamate DehydrogenaseLiverLiver TransplantationMannitolNitric Oxide Synthase Type IIIOrgan PreservationOrgan Preservation SolutionsPotassium ChlorideProcaineAdenosine TriphosphateAlanine TransaminaseAMP-Activated Protein Kinase KinasesAspartate AminotransferasesATP dependent 26S proteaseBretschneider cardioplegic solutionGlucoseGlutamate DehydrogenaseIGL-1 solutionMannitolNitric Oxide Synthase Type IIIOrgan Preservation SolutionsPotassium ChlorideProcaineProteasome Endopeptidase ComplexProtein KinasesAMPK and nitric oxideATPcold ischemic injuryfatty liver preservationHTKIGL-1ubiquitin proteasome system

Identifiers

PMID29088097
PMCPMC5713257
OpenAlexW2766886822

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.